vs
Side-by-side financial comparison of KeyCorp (KEY) and Kenvue (KVUE). Click either name above to swap in a different company.
Kenvue is the larger business by last-quarter revenue ($3.8B vs $2.0B, roughly 1.9× KeyCorp). KeyCorp runs the higher net margin — 25.4% vs 8.7%, a 16.7% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs 3.2%). KeyCorp produced more free cash flow last quarter ($2.1B vs $744.0M). Over the past eight quarters, KeyCorp's revenue compounded faster (14.4% CAGR vs -1.5%).
Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
KEY vs KVUE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $3.8B |
| Net Profit | $510.0M | $330.0M |
| Gross Margin | — | 56.5% |
| Operating Margin | 32.3% | 14.2% |
| Net Margin | 25.4% | 8.7% |
| Revenue YoY | 131.8% | 3.2% |
| Net Profit YoY | 309.0% | 12.6% |
| EPS (diluted) | $0.43 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $3.8B | ||
| Q3 25 | $1.9B | $3.8B | ||
| Q2 25 | $1.8B | $3.8B | ||
| Q1 25 | $1.8B | $3.7B | ||
| Q4 24 | $865.0M | $3.7B | ||
| Q3 24 | $695.0M | $3.9B | ||
| Q2 24 | $1.5B | $4.0B | ||
| Q1 24 | $1.5B | $3.9B |
| Q4 25 | $510.0M | $330.0M | ||
| Q3 25 | $489.0M | $398.0M | ||
| Q2 25 | $425.0M | $420.0M | ||
| Q1 25 | $405.0M | $322.0M | ||
| Q4 24 | $-244.0M | $293.0M | ||
| Q3 24 | $-410.0M | $383.0M | ||
| Q2 24 | $274.0M | $58.0M | ||
| Q1 24 | $219.0M | $296.0M |
| Q4 25 | — | 56.5% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | — | 58.9% | ||
| Q1 25 | — | 58.0% | ||
| Q4 24 | — | 56.5% | ||
| Q3 24 | — | 58.5% | ||
| Q2 24 | — | 59.1% | ||
| Q1 24 | — | 57.6% |
| Q4 25 | 32.3% | 14.2% | ||
| Q3 25 | 31.8% | 16.7% | ||
| Q2 25 | 29.3% | 18.0% | ||
| Q1 25 | 29.0% | 14.9% | ||
| Q4 24 | -92.6% | 13.2% | ||
| Q3 24 | -72.8% | 16.8% | ||
| Q2 24 | 22.0% | 3.9% | ||
| Q1 24 | 18.1% | 14.1% |
| Q4 25 | 25.4% | 8.7% | ||
| Q3 25 | 25.8% | 10.6% | ||
| Q2 25 | 23.1% | 10.9% | ||
| Q1 25 | 22.8% | 8.6% | ||
| Q4 24 | -54.7% | 8.0% | ||
| Q3 24 | -59.0% | 9.8% | ||
| Q2 24 | 18.0% | 1.5% | ||
| Q1 24 | 14.3% | 7.6% |
| Q4 25 | $0.43 | $0.16 | ||
| Q3 25 | $0.41 | $0.21 | ||
| Q2 25 | $0.35 | $0.22 | ||
| Q1 25 | $0.33 | $0.17 | ||
| Q4 24 | $-0.30 | $0.16 | ||
| Q3 24 | $-0.47 | $0.20 | ||
| Q2 24 | $0.25 | $0.03 | ||
| Q1 24 | $0.20 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2B | $1.1B |
| Total DebtLower is stronger | $9.9B | — |
| Stockholders' EquityBook value | $20.4B | $10.8B |
| Total Assets | $184.4B | $27.1B |
| Debt / EquityLower = less leverage | 0.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.2B | $1.1B | ||
| Q3 25 | $13.3B | $1.1B | ||
| Q2 25 | $11.6B | $1.1B | ||
| Q1 25 | $15.3B | $1.1B | ||
| Q4 24 | $17.5B | $1.1B | ||
| Q3 24 | $22.8B | $1.1B | ||
| Q2 24 | $15.5B | $1.0B | ||
| Q1 24 | $13.2B | $1.2B |
| Q4 25 | $9.9B | — | ||
| Q3 25 | $10.9B | — | ||
| Q2 25 | $12.1B | — | ||
| Q1 25 | $12.4B | — | ||
| Q4 24 | $12.1B | — | ||
| Q3 24 | $15.7B | — | ||
| Q2 24 | $16.9B | — | ||
| Q1 24 | $20.8B | — |
| Q4 25 | $20.4B | $10.8B | ||
| Q3 25 | $20.1B | $10.6B | ||
| Q2 25 | $19.5B | $10.7B | ||
| Q1 25 | $19.0B | $10.1B | ||
| Q4 24 | $18.2B | $9.7B | ||
| Q3 24 | $16.9B | $10.6B | ||
| Q2 24 | $14.8B | $10.2B | ||
| Q1 24 | $14.5B | $10.6B |
| Q4 25 | $184.4B | $27.1B | ||
| Q3 25 | $187.4B | $27.2B | ||
| Q2 25 | $185.5B | $27.1B | ||
| Q1 25 | $188.7B | $26.3B | ||
| Q4 24 | $187.2B | $25.6B | ||
| Q3 24 | $189.8B | $26.9B | ||
| Q2 24 | $187.4B | $26.4B | ||
| Q1 24 | $187.5B | $27.3B |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 0.93× | — | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2B | $854.0M |
| Free Cash FlowOCF − Capex | $2.1B | $744.0M |
| FCF MarginFCF / Revenue | 104.8% | 19.7% |
| Capex IntensityCapex / Revenue | 5.3% | 2.9% |
| Cash ConversionOCF / Net Profit | 4.33× | 2.59× |
| TTM Free Cash FlowTrailing 4 quarters | $3.5B | $1.7B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2B | $854.0M | ||
| Q3 25 | $396.0M | $294.0M | ||
| Q2 25 | $1.2B | $621.0M | ||
| Q1 25 | $-140.0M | $428.0M | ||
| Q4 24 | $664.0M | $793.0M | ||
| Q3 24 | $-1.2B | $249.0M | ||
| Q2 24 | $-217.0M | $440.0M | ||
| Q1 24 | $359.0M | $287.0M |
| Q4 25 | $2.1B | $744.0M | ||
| Q3 25 | $367.0M | $196.0M | ||
| Q2 25 | $1.2B | $533.0M | ||
| Q1 25 | $-150.0M | $249.0M | ||
| Q4 24 | $599.0M | $661.0M | ||
| Q3 24 | $-1.2B | $190.0M | ||
| Q2 24 | $-230.0M | $350.0M | ||
| Q1 24 | $347.0M | $134.0M |
| Q4 25 | 104.8% | 19.7% | ||
| Q3 25 | 19.4% | 5.2% | ||
| Q2 25 | 65.8% | 13.9% | ||
| Q1 25 | -8.5% | 6.7% | ||
| Q4 24 | 69.2% | 18.1% | ||
| Q3 24 | -175.8% | 4.9% | ||
| Q2 24 | -15.1% | 8.8% | ||
| Q1 24 | 22.6% | 3.4% |
| Q4 25 | 5.3% | 2.9% | ||
| Q3 25 | 1.5% | 2.6% | ||
| Q2 25 | 1.3% | 2.3% | ||
| Q1 25 | 0.6% | 4.8% | ||
| Q4 24 | 7.5% | 3.6% | ||
| Q3 24 | 2.4% | 1.5% | ||
| Q2 24 | 0.9% | 2.3% | ||
| Q1 24 | 0.8% | 3.9% |
| Q4 25 | 4.33× | 2.59× | ||
| Q3 25 | 0.81× | 0.74× | ||
| Q2 25 | 2.90× | 1.48× | ||
| Q1 25 | -0.35× | 1.33× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 0.65× | ||
| Q2 24 | -0.79× | 7.59× | ||
| Q1 24 | 1.64× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KEY
Segment breakdown not available.
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
